BETACARBOLINE DERIVATIVES AS GABA A-RECEPTOR-MODULATORS HAVING NMDA-ANTAGONISTIC ACTIVITY FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM

摘要

The invention relates to the use of GABAA receptor modulators having NMDA-antagonistic activity for the production of a medicament for neuroprotection and the combination of GABAA receptor modulators having NMDA-antagonistic effects and alpha -liponic acid or dihydro- alpha -liponic acid.